OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Click here to read the articles and download the PDF
Click here to read Pharm Exec's latest listing of the top global biopharma sales producers.
Click here to read the profiles of 13 diverse leaders vital to the future of the biopharma industry.
Click here to read June's Executive Profile on Michelle McMurry-Heath, president and CEO of BIO.
This Pharmaceutical CEO Leadership roundtable brings together pharma Chief Digital Officers and other leaders in the space to discuss the challenges and opportunities associated with digitizing all aspects of the pharma business.
The Healthcare Businesswomen’s Association again names Sandra Horning its WoTY—where the pharma leader’s message of purpose and partnership takes on added resonance today.
With a complicated and challenging global picture greeting the new year, driven by the continuing pandemic and historic political and regulatory changes in the US and Europe, we outline eight diverse trends critical to biopharma’s future health and growth.
June 14, 2021
Small companies that want to develop an environmental, social, and corporate governance (ESG) program should start the process by defining their goals and identifying the initiatives that their peers and competitors tend to focus on.
June 11, 2021
FDA’s surprise decision this week to approve Biogen’s treatment for Alzheimer’s Disease has raised serious questions about the validity and value of the agency’s accelerated approval process.
June 10, 2021
Judy Stewart, head of US vaccines at GSK, talks about the effects of people missing their recommended vaccinations during the pandemic and the importance of delivering a message of value for vaccines.
Tina and Kathy Delaney, CCO of Publicis Health/Saatchi Wellness, chat about creative inspiration, trends and surreal career moments.
June 09, 2021
Pandemic-reinforced principles of successful drug launch.
In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
How Gilead readied remdesivir for the COVID challenge.
Inside Regeneron’s monoclonal antibody development to treat COVID.
Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.
Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.